| Synonyms: | |
| Status: | Approved (2000) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | A02BC02 |
| UNII: | D8TST4O562 |
| InChI Key | IQPSEEYGBUAQFF-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H15F2N3O4S |
| Molecular Weight | 383.38 |
| AlogP | 2.88 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 86.33 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 26.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 1000 | - | - | - | |
|
Enzyme
Oxidoreductase
|
- | 12600 | - | - | - | |
|
Enzyme
Transferase
|
- | 36200 | - | 4100 | - | |
|
Enzyme
|
- | 1000 | - | 4100 | 0 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 15-81 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 1500 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC47 family of multidrug and toxin extrusion transporters
|
- | 2800-43200 | - | - | - | |
|
Transporter
Primary active transporter
P-type ATPase
Hydrogen potassium ATPase
|
- | 1000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus | 3 | D003920 | ClinicalTrials |
| Laryngopharyngeal Reflux | 3 | D057045 | ClinicalTrials |
| Hemorrhage | 3 | D006470 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Barrett Esophagus | 3 | D001471 | ClinicalTrials |
| Ulcer | 3 | D014456 | ClinicalTrials |
| Gastrointestinal Hemorrhage | 3 | D006471 | ClinicalTrials |
| Esophageal Diseases | 3 | D004935 | ClinicalTrials |
| Esophagitis | 2 | D004941 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
| Zollinger-Ellison Syndrome | 2 | D015043 | ClinicalTrials |
| Helicobacter Infections | 2 | D016481 | ClinicalTrials |
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Gastrinoma | 2 | D015408 | ClinicalTrials |
| Acute Coronary Syndrome | 1 | D054058 | ClinicalTrials |
| Bacterial Infections | 1 | D001424 | ClinicalTrials |
| Aspergillosis | 1 | D001228 | ClinicalTrials |
| Multiple Sclerosis | 1 | D009103 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 102625-70-7 |
| ChEBI | 7915 |
| ChEMBL | CHEMBL1502 |
| DrugBank | DB00213 |
| DrugCentral | 2054 |
| EPA CompTox | DTXSID4023416 |
| FDA SRS | D8TST4O562 |
| Human Metabolome Database | HMDB0005017 |
| Guide to Pharmacology | 7260 |
| KEGG | C11806 |
| PharmGKB | PA450774 |
| PubChem | 4679 |
| SureChEMBL | SCHEMBL29465 |